In a pivotal development within the medical imaging and technology realm, iCardio.ai, a prominent player in AI-driven ultrasound interpretation, has established a strategic partnership with UltraLinQ

Bausch + Lomb Corporation has recently received approval from the U.S. Food and Drug Administration (FDA) for its innovative TENEO Excimer Laser Platform

Paragon 28, Inc. is pleased to announce the launch of the Grappler? Knotless Anchor System and Bridgeline? Tape, further solidifying its position in the dynamic foot and ankle soft tissue

Alamar Biosciences recently unveiled the commercial release of its ARGO HT System and NULISAseq Inflammation Panel 250, marking a significant stride in the realm of precision proteomics.

Empassion Health and Theoria Medical have recently announced a strategic partnership aimed at enhancing patient care on a national scale. This collaboration is designed to broaden services

K2 Medical Research, a clinical research facility located in the greater Orlando area, has joined forces with Magruder Eye Institute and RetiSpec for a research pilot aimed at enhancing clinical trial accessibility.

Pulse Biosciences, a company with a primary focus on utilizing its innovative CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for treating atrial fibrillation, has officially submitted a premarket notification 510(k) to the U.S.

Terveystalo, Finland's leading healthcare provider, has integrated Nightingale Health?s advanced blood analysis technology into its routine occupational health assessments.

PharmaSens AG, a Swiss company dedicated to improving access to insulin pump therapy, has successfully submitted its FDA approval

SeaStar Medical Holding Corporation, a company specializing in medical devices designed to address hyperinflammation's impact on vital organs, has reported the enrollment